National Academy of Medical Sciences of Ukraine
State Institution "The National Research Center for Radiation Medicine"


ISSN 2313-4607 (Online)
ISSN 2304-8336 (Print)

Problems of Radiation Medicine and Radiobiology

  
 

   

O. O. Shumeiko1,2, L. O. Poluben1, B. T. Klimuk1, L. A. Rybchenko1, L. V. Neumerzhitskaya1,
R. M. Verbilenko1, S. V. Frolov2, S. V. Klymenko1,2

1State Institution National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine, 53 Melnykova str., Kyiv, 04050, Ukraine
2Bogomolets National Medical University, 13, Tarasa Shevchenko Blvd, Kyiv, 01601, Ukraine

EVALUATION OF BURDENSOME SYMPTOMS IN PATIENTS WITH RADIATION/ASSOCIATED AND SPONTANEOUS MYELOPROILIFERATIVE NEOPLASMS WITH THE USE OF OPTIMIZED SELF/ASSESSMENT MPN/SAF TSS

Objective. To investigate the intensity of burdensome symptoms using self-assessment MPN-SAF TSS in patients with radiation-associated and spontaneous myeloproiliferative neoplasms (MPNs).
Materials and methods. The study included 89 patients with radiation-associated and spontaneous MPNs, the burdensome symptoms of MPN were determined using MPN-SAF TSS.
Results. The average score for complaints in patients with radiation-associated MPNs was significantly higher than in patients with spontaneous MPNs 43.46 and 25.04 points, respectively (p = 0.003). MPN patients classified by subtypes also showed differences regarding intensity of burdensome MPN symptoms, demonstrating significantly higher average score of complaints among primary myelofibrosis patients (35.60), compared to polycythemia vera (29.60) and essential thrombocythemia (18.05) patients, (p = 0.005). Our study did not reveal any influence of the JAK2 V617F mutation on MPN burdensome symptoms intensity in MPN patients.
Conclusions. We demonstrated a higher intensity of the MPN burdensome symptoms determined by the optimized self-assessment MPN-SAF TSS in patients with radiation-associated, and in primary myelofibrosis patients, indicating increased severity of patients general conditions at the stage of diagnosis verification. It is advisable to use the optimized MPN-SAF TSS at the moment of molecular genetic testing during the diagnosis of MPN for selection or modifying treatment strategies in order to achieve better quality of life for patients
Key words: Myeloproliferative neoplasms, ionizing radiation, MPN-SAF TSS, JAK2 V617F mutation.

Problems of radiation medicine and radiobiology.
2018;23:510516. doi: 10.33145/2304-8336-2018-23-510-516.

full text





Home | Editorial board | For Authors | Archive | Search
© 2013 Problems of Radiation Medicine